A Louvigné-de-Bais (Ille-et-Vilaine), la carrière Pigeon s'étend sur une surface de 128 hectares. Son activité est consacrée à la production et à la valorisation des granulats.

Wondering if Roche Holding might be a hidden gem in today’s market? You’re not alone, as many investors are taking a closer look at what makes this pharmaceutical giant’s stock interesting right now.

If you have been watching Roche Holding (SWX:ROG), you might be wondering what to make of its recent run. The stock’s movement lately has caught the eye of many investors, not because of a ...

Roche Holding AG will move an experimental obesity shot into late-stage trials next year in a bid to challenge leaders in the booming market for weight-loss medicines. The drug, known as CT-388, ...

There are two FDA-approved medications for the metabolic disorder known as MASH. Roche is paying $2.4 billion to acquire 89bio and its late-stage MASH drug, giving the Swiss pharmaceutical giant the ...

Roche's acquisition of 89bio aims to strengthen its portfolio in cardiovascular, renal, and metabolic diseases, focusing on obesity-related comorbidities like MASH. The merger agreement includes a $14 ...

Roche Diagnostics will invest $550 million in its Indianapolis base to construct a new manufacturing facility for glucose monitoring devices, which will add several hundred jobs and further solidify ...

Last month, Roche committed $50 billion in U.S. manufacturing funds, with which it will construct at least four new facilities. Roche has pledged an RMB 2 billion infusion into its Chinese footprint, ...

Even as Roche makes a major investment pledge across its U.S. business, the Swiss pharmaceutical giant isn’t neglecting its chief markets in Asia. Roche is investing roughly 2.04 billion Chinese yuan ...

Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning the President Trump administration for an exemption. Roche is trying to ...

Roche is pledging to invest $50 billion in manufacturing and research infrastructure in the U.S. over the next five years, making the pharmaceutical giant the latest company to unveil a capital ...

Roche will invest $50 billion in American manufacturing over the next five years, including building a new facility somewhere in Indiana.The Swiss biotech company said the investment will eventually ...